Guide · Bloodwork

TRT blood test markers explained

A TRT panel arrives as a column of numbers with no story attached. This guide explains what each marker actually measures, why it is followed on testosterone therapy, and why the trend across draws carries more information than any single value.

TRT AI editorial team· Updated · 7 min read·Informational, not medical advice

Informational only

This page is educational. It is not medical advice, it is not a dosing instruction, and it is not a substitute for the clinician who prescribes and monitors your therapy. TRT AI is a tracking tool: it records what you were prescribed and what your labs said. It does not recommend, calculate or adjust medication doses. Never start, stop or change a protocol — or act on a lab value — without the clinician who ordered it.

On this page

  1. What a TRT panel can and cannot tell you
  2. The markers, one at a time
  3. What a reference range is — and what it is not
  4. Reading a trend instead of a number
  5. How often panels are repeated
  6. Common questions

What a TRT panel can and cannot tell you

A blood draw is a snapshot of one morning. Testosterone follows a daily rhythm, injected esters follow a weekly one, and two laboratories running different platforms can return meaningfully different numbers from the same tube. That is why the Endocrine Society clinical practice guideline anchors diagnosis on repeated fasting morning measurements rather than a single result, and confirms an abnormal value before anyone acts on it.

Once you are on therapy the same logic holds, for a different reason: what changes on a protocol is usually slow and small. A panel is useful when it is comparable — same laboratory, same assay, same point in the injection interval, same time of day. Comparability is the part you control. Interpretation is the part your clinician does.

The markers, one at a time

These are the twelve markers TRT AI tracks on one timeline, because they are the ones that recur on TRT panels. What each one is does not change between clinics; what a given value means for you is a clinical judgement.

MarkerWhat it measuresWhy it is followed on TRT
Total testosterone All testosterone in serum — the fraction bound to SHBG, the fraction bound to albumin and the small unbound fraction together. The headline number. Guidelines frame both diagnosis and on-treatment monitoring around it.
Free testosterone The unbound fraction only — roughly 1–3% of the total in most men. Requested when total testosterone and symptoms disagree, which is usually an SHBG story.
SHBG Sex hormone-binding globulin — the transport protein that binds testosterone tightly. Sets how much of a given total testosterone is free. Two men with identical total T and different SHBG are not in the same place.
Estradiol (E2) The estrogen produced from testosterone by the aromatase enzyme. Has its own physiology in men — bone, body fat and sexual function — so it is followed as a value in its own right, not as a by-product.
Hematocrit The percentage of blood volume made up of red cells. The most consistently monitored safety marker on testosterone therapy; guidelines set explicit thresholds for clinicians.
Hemoglobin The oxygen-carrying protein inside red cells. Moves with hematocrit and is reported on the same complete blood count. The Depo-Testosterone label directs that both be checked periodically during long-term androgen use.
PSA Prostate-specific antigen, a protein produced by prostate tissue. Prostate-safety marker. The guideline sets pre-treatment limits and pays particular attention to the first year of therapy.
LH and FSH Pituitary signalling hormones that instruct the testes. Used before therapy to separate testicular from pituitary causes. Exogenous testosterone suppresses both, so on-treatment values mostly confirm suppression.
Prolactin A pituitary hormone. Part of the standard work-up when low testosterone is being investigated.
DHEA-S, cortisol, TSH Adrenal and thyroid context. Fatigue, low mood and low libido are not testosterone-specific. These markers exist on the panel so the obvious alternatives are visible.

What a reference range is — and what it is not

The interval printed next to your result is a reference interval: the central range of values seen in that laboratory's reference population, on that laboratory's platform. It is a description of other people, not a target for you, and not a personalised goal. Three consequences follow.

For free testosterone the method matters as much as the range — calculated, direct-analog and equilibrium-dialysis results are not interchangeable. That is the subject of a separate guide on free testosterone and SHBG.

Reading a trend instead of a number

One draw tells you where you were on one morning. Three comparable draws start to describe a direction, and direction is what a protocol conversation is actually about. To get comparable draws, hold the variables still: the same laboratory, the same assay, the same time of day, the same position in your injection interval, and a note of when your last dose actually landed.

Everything that moves the number should be written down next to it — a changed dose, a missed or shifted injection, a blood donation, a bout of illness, a new supplement, a hard training block before the draw. A lab value without that context is a number; with it, it is evidence.

TRT AI lab marker timeline showing successive draws for one marker against its range band
TRT AI plots each marker across draws, with your protocol on the same timeline.

How often panels are repeated

Cadence is a clinical decision, and it varies by history and by country. As a reference point, the Endocrine Society guideline describes reassessing hematocrit at 3–6 months after starting therapy and annually thereafter, measuring testosterone in the same 3–6 month window and then annually, and paying particular attention to prostate risk during the first year in men for whom PSA monitoring is appropriate. The AUA guidance likewise directs clinicians to measure haemoglobin and hematocrit and to counsel patients about the risk of polycythaemia before therapy begins.

Those are instructions written for clinicians. Practically, what they mean for you is that a panel is due more often than you would guess in the first year and less often than forum advice suggests after that — and that the appointment goes better when you arrive with the previous draws already lined up.

Common questions

Can I interpret my own TRT panel?

You can understand what each marker measures, keep your draws comparable and notice a trend — all of which makes a consultation more productive. What a value means for your therapy, and what should change as a result, is a clinical decision that needs your history, your examination and your prescriber.

Why did my numbers change when I switched labs?

Different platforms and assays give different results, and each laboratory publishes its own reference interval. A switch starts a new series rather than continuing the old one. Where a choice exists, staying with one laboratory makes your trend readable.

Which markers matter most on TRT?

Guidelines put the most consistent monitoring weight on testosterone itself and on hematocrit, with prostate monitoring for men in the relevant age and risk groups. Beyond that, which extras are useful depends on your presentation — which is exactly why the decision belongs to your clinician.

Sources

  1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. pubmed.ncbi.nlm.nih.gov/29562364/
  2. American Urological Association. Evaluation and Management of Testosterone Deficiency (2018; reviewed and validity confirmed 2024). www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
  3. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666–3672. pubmed.ncbi.nlm.nih.gov/10523012/
  4. DEPO-TESTOSTERONE (testosterone cypionate) injection, solution — FDA-approved label, Pharmacia & Upjohn Company LLC. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=735b5bf3-4464-412c-a072-1bd02f2e5380

Sources were checked on 25 July 2026. Guideline documents are revised — always read the current version, and read it with the clinician who knows your case.